McDonnell Genome Institute

McDonnell Genome Institute
Name	McDonnell Genome Institute
Established	1993
Type	Research institute
Location	St. Louis, Missouri
Director	Richard K. Wilson
Affiliation	Washington University School of Medicine

McDonnell Genome Institute

The McDonnell Genome Institute is a genomic research center at Washington University School of Medicine in St. Louis affiliated with the Genome Institute and focused on large-scale sequencing and analysis. The institute conducts projects across human disease, cancer, infectious disease, evolutionary biology, and precision medicine, contributing data to repositories and consortia while partnering with universities, government agencies, and industry. Its work has informed initiatives in cancer genomics, pathogen surveillance, and population sequencing, and has influenced policies and standards used by organizations worldwide.

History

The institute originated from investments by William H. Danforth and the Dana and David Dornsife families and was shaped by leadership including Maynard V. Olson, Eric Lander, and James L. Weber, linking it to early efforts such as the Human Genome Project, the National Institutes of Health initiatives, and the International HapMap Project. During the 1990s and 2000s it expanded sequencing capacity through collaborations with the Broad Institute, Baylor College of Medicine, and the Sanger Centre while contributing to consortia like the 1000 Genomes Project and The Cancer Genome Atlas. Key transitions involved adoption of next-generation sequencing platforms from Illumina and Pacific Biosciences and integration of computational frameworks developed with partners including the National Human Genome Research Institute, the National Cancer Institute, and the Centers for Disease Control and Prevention. Leadership changes and philanthropic support from the J. William and Mary D. McDonnell Foundation helped rebrand and grow the institute into a hub connected to initiatives such as the Human Microbiome Project, the Global Virome Project, and international sequencing networks.

Mission and Research Programs

The institute's mission emphasizes genomic discovery in biomedical research, translational genomics, and data sharing, aligning with programmatic efforts in cancer genomics, infectious disease genomics, constitutional genomics, and comparative genomics. Research programs target tumor characterization in partnership with the International Cancer Genome Consortium, pathogen genomics in collaboration with the World Health Organization and the Pan American Health Organization, and precision oncology projects tied to the American Association for Cancer Research and the Clinical Proteomic Tumor Analysis Consortium. Initiatives support population genomics studies linked to the National Institutes of Health All of Us Research Program and population genetics projects with the Broad Institute and the Wellcome Sanger Institute. The institute also contributes to standards and best practices promulgated by the Global Alliance for Genomics and Health and the American College of Medical Genetics and Genomics.

Facilities and Technology

Facilities include high-throughput sequencing centers housing Illumina NovaSeq, PacBio Sequel, Oxford Nanopore platforms, and robotic sample-processing systems acquired through collaborations with companies such as Thermo Fisher Scientific and Agilent Technologies. Computational infrastructure incorporates large-scale clusters, cloud-based resources through Amazon Web Services and Google Cloud Platform, and data management systems interoperable with repositories like the Sequence Read Archive, dbGaP, and GenBank. Bioinformatics pipelines adapt tools from the Broad Institute's GATK, the European Bioinformatics Institute, and the National Center for Biotechnology Information while leveraging visualization and analysis platforms used by institutions such as the University of California, Santa Cruz Genome Browser and Ensembl. Core facilities support clinical laboratory operations under regulatory frameworks established by the College of American Pathologists and the Clinical Laboratory Improvement Amendments and maintain quality standards familiar to partners including the Food and Drug Administration.

Major Projects and Contributions

Major contributions include participation in The Cancer Genome Atlas with the National Cancer Institute and the National Human Genome Research Institute, pathogen sequencing during outbreaks linked to the Centers for Disease Control and Prevention and the World Health Organization, and generation of reference genomes used by Ensembl, UCSC, and the International Nucleotide Sequence Database Collaboration. The institute produced data for studies published in journals such as Nature, Science, and Cell and contributed analytic methods alongside groups at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute. Notable projects include large-scale tumor-normal sequencing in collaboration with the American Association for Cancer Research and integrative analyses with the Clinical Proteomic Tumor Analysis Consortium, rapid sequencing responses during Ebola and Zika outbreaks in concert with the Pan American Health Organization and Médecins Sans Frontières, and population-focused sequencing tied to the 1000 Genomes Project and the All of Us Research Program.

Collaborations and Partnerships

The institute maintains partnerships with Washington University School of Medicine, BJC HealthCare, the Broad Institute, the Wellcome Sanger Institute, Baylor College of Medicine, and the National Institutes of Health, and engages with philanthropic entities including the J. William and Mary D. McDonnell Foundation and the Danforth Foundation. It participates in international consortia such as the International Cancer Genome Consortium, the Global Virome Project, and the Human Cell Atlas, and works with regulatory and public health organizations including the Centers for Disease Control and Prevention, the Food and Drug Administration, and the World Health Organization. Academic collaborations extend to Harvard University, Stanford University, Johns Hopkins University, University of California system campuses, and the European Molecular Biology Laboratory, while industry partnerships include Illumina, PacBio, Oxford Nanopore Technologies, and cloud providers Amazon and Google.

Education and Outreach

Educational programs involve graduate and postdoctoral training linked to Washington University School of Medicine, workshops with the American Association for Cancer Research, and internships engaging students from institutions such as Saint Louis University, University of Missouri, and community colleges. Outreach includes public engagement with the Saint Louis Science Center, genome literacy initiatives in collaboration with the National Institutes of Health and the Smithsonian Institution, and policy dialogues with organizations like the Global Alliance for Genomics and Health and the American College of Medical Genetics and Genomics. The institute also contributes to open data principles embraced by the Sequence Read Archive, GenBank, and dbGaP to promote reproducibility with partners such as the Broad Institute and the European Bioinformatics Institute.

Category:Genomics research institutes Category:Washington University in St. Louis